[1]

Chen S, Kuhn M, Prettner K, Yu F, Yang T, et al. 2023. The global economic burden of chronic obstructive pulmonary disease for 204 countries and territories in 2020-50: a health-augmented macroeconomic modelling study. The Lancet Global Health 11:e1183−e1193

doi: 10.1016/S2214-109X(23)00217-6
[2]

Hoogendoorn M, Hoogenveen RT, Rutten-van Mölken MP, Vestbo J, Feenstra TL. 2011. Case fatality of COPD exacerbations: a meta-analysis and statistical modelling approach. The European Respiratory Journal 37:508−15

doi: 10.1183/09031936.00043710
[3]

Gutiérrez Villegas C, Paz-Zulueta M, Herrero-Montes M, Parás-Bravo P, Madrazo Pérez M. 2021. Cost analysis of chronic obstructive pulmonary disease (COPD): a systematic review. Health Economics Review 11:31

doi: 10.1186/s13561-021-00329-9
[4]

Hurst JR, Han MK, Singh B, Sharma S, Kaur G, et al. 2022. Prognostic risk factors for moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease: a systematic literature review. Respiratory Research 23:213

doi: 10.1186/s12931-022-02123-5
[5]

Williams PJ, Cumella A, Philip KEJ, Laverty AA, Hopkinson NS. 2022. Smoking and socioeconomic factors linked to acute exacerbations of COPD: analysis from an Asthma + Lung UK survey. BMJ Open Respiratory Research 9:e001290

doi: 10.1136/bmjresp-2022-001290
[6]

Wu J, Meng W, Ma Y, Zhao Z, Xiong R, et al. 2024. Early smoking lead to worse prognosis of COPD patients: a real world study. Respiratory Research 25:140

doi: 10.1186/s12931-024-02760-y
[7]

Shah CH, Reed RM, Wastila L, Onukwugha E, Gopalakrishnan M, et al. 2023. Direct Medical Costs of COPD in the USA: an analysis of the medical expenditure panel survey 2017−2018. Applied Health Economics and Health Policy 21:915−24

doi: 10.1007/s40258-023-00814-8
[8]

Li J, Su J, Tong Z, Liang L. 2024. Utilizing EMR data for smoking behavior surveillance in hospitalized patients with chronic respiratory diseases and its impact on clinical outcomes - Beijing municipality, China, 2014−2023. China CDC Weekly 6:530−34

doi: 10.46234/ccdcw2024.101
[9]

Liang L, Li C, Shen Y, Zhou L, Jing H, et al. 2019. Test information extraction for electronic medical record based on cascaded conditional random field model. Computer Applications and Software 36:47−54 (in Chinese)

doi: 10.3969/j.issn.1000-386x.2019.10.009
[10]

Soriano JB, Abajobir AA, Abate KH, Abera SF, Agrawal A, et al. 2017. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990−2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet Respiratory Medicine 5:691−706

doi: 10.1016/S2213-2600(17)30293-X
[11]

Wang C, Xu J, Yang L, Xu Y, Zhang X, et al. 2018. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health study): a national cross-sectional study. The Lancet 391:1706−17

doi: 10.1016/S0140-6736(18)30841-9
[12]

Jiang C, Chen Q, Xie M. 2020. Smoking increases the risk of infectious diseases: a narrative review. Tobacco Induced Diseases 18:60

doi: 10.18332/tid/123845
[13]

Love ME, Proud D. 2022. Respiratory viral and bacterial exacerbations of COPD—the role of the airway epithelium. Cells 11:1416

doi: 10.3390/cells11091416
[14]

Steinberg MB, Akincigil A, Kim EJ, Shallis R, Delnevo CD. 2016. Tobacco smoking as a risk factor for increased antibiotic prescription. American Journal of Preventive Medicine 50:692−98

doi: 10.1016/j.amepre.2015.11.009
[15]

Blix HS, Hjellvik V, Litleskare I, Rønning M, Tverdal A. 2011. Cigarette smoking and risk of subsequent use of antibacterials: a follow-up of 365, 117 men and women. Journal of Antimicrobial Chemotherapy 66:2159−67

doi: 10.1093/jac/dkr273
[16]

Stanton N, Hood K, Kelly MJ, Nuttall J, Gillespie D, et al. 2010. Are smokers with acute cough in primary care prescribed antibiotics more often, and to what benefit? An observational study in 13 European countries. European Respiratory Journal 35:761−67

doi: 10.1183/09031936.00168409
[17]

Xu J, Zeng Q, Li S, Su Q, Fan H. 2024. Inflammation mechanism and research progress of COPD. Frontiers in Immunology 15:1404615

doi: 10.3389/fimmu.2024.1404615
[18]

Bhatt SP, Anderson JA, Brook RD, Calverley PMA, Celli BR, et al. 2018. Cigarette smoking and response to inhaled corticosteroids in COPD. The European Respiratory Journal 51:1701393

doi: 10.1183/13993003.01393-2017
[19]

Nielsen AO, Lange P, Hilberg O, Farver-Vestergaard I, Ibsen R, et al. 2024. COPD and smoking status - it does matter: characteristics and prognosis of COPD according to smoking status. Chronic Obstructive Pulmonary Diseases 11:56−67

doi: 10.15326/jcopdf.2023.0433
[20]

Adibi A, Sin DD, Safari A, Johnson KM, Aaron SD, et al. 2020. The acute COPD exacerbation prediction tool (ACCEPT): a modelling study. The Lancet Respiratory Medicine 8:1013−21

doi: 10.1016/S2213-2600(19)30397-2
[21]

Liang L, Shang Y, Xie W, Shi J, Tong Z, et al. 2020. Trends in hospitalization expenditures for acute exacerbations of COPD in Beijing from 2009 to 2017. International Journal of Chronic Obstructive Pulmonary Disease 15:1165−75

doi: 10.2147/COPD.S243595
[22]

Zhang YY, Tang WT, Zhang H, Wang J, Bai XX, et al. 2022. Barriers and facilitators for smoking cessation in Chinese smokers with chronic obstructive pulmonary disease: a qualitative study. International Journal of Chronic Obstructive Pulmonary Disease 17:1107−20

doi: 10.2147/COPD.S356935
[23]

Jiménez-Ruiz CA, Andreas S, Lewis KE, Tonnesen P, van Schayck CP, et al. 2015. Statement on smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quit. The European Respiratory Journal 46:61−79

doi: 10.1183/09031936.00092614
[24]

van Eerd EAM, van der Meer RM, van Schayck OCP, Kotz D. 2016. Smoking cessation for people with chronic obstructive pulmonary disease. The Cochrane Database of Systematic Reviews 2016:Cd010744

doi: 10.1002/14651858.CD010744.pub2
[25]

Backman H. 2024. 10 pack-years of smoking: not the magic number for COPD risk and prognosis. The European Respiratory Journal 64:2401230

doi: 10.1183/13993003.01230-2024